After years of research and campaigning, we’re closer than ever to a prostate cancer screening programme. Here’s why 2025 could be the year things finally change.

And why Starmer is "better"at foreign policy than domestic

The authors show that DCAF1, a substrate receptor of CUL4 and EDVP E3 ligases, can be recruited by PROTACs to degrade the cancer drug target, WDR5. They also report the crystal structures of PROTAC te...